RIA
CANO

RP Investment Advisors’s Cano Health, Inc. CANO Stock Holding History

RP Investment Advisors’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,275
Closed -$14.9M – 54
2020
Q3 		$14.9M Buy
+14,275
New +$14.9M 5.16% 3

Other funds holding CANO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

RP Investment Advisors's CANO Position: Q4 2020 in Review

RP Investment Advisors sold out of Cano Health, Inc. (CANO) in Q4 2020, closing a stake of 14,275 shares — an estimated $14.9M sold.

RP Investment Advisors first reported a position in CANO in Q3 2020 and held it in 1 quarter. The position peaked at $14.9M in Q3 2020. 81 funds tracked by Wall St. Rank hold CANO as of Q4 2020.

  • RP Investment Advisors reported no remaining Cano Health, Inc. position as of Q4 2020 after selling out during the quarter.
  • RP Investment Advisors sold 14,275 Cano Health, Inc. shares in Q4 2020, an estimated $14.9M.
  • RP Investment Advisors first reported a position in Cano Health, Inc. in Q3 2020 and held it in 1 quarter.
  • RP Investment Advisors's Cano Health, Inc. position peaked at $14.9M in Q3 2020.
  • 81 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2020.

Based on RP Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.